PL382842A1 - Sole donepezilu odpowiednie do otrzymywania kompozycji farmaceutycznych - Google Patents
Sole donepezilu odpowiednie do otrzymywania kompozycji farmaceutycznychInfo
- Publication number
- PL382842A1 PL382842A1 PL382842A PL38284205A PL382842A1 PL 382842 A1 PL382842 A1 PL 382842A1 PL 382842 A PL382842 A PL 382842A PL 38284205 A PL38284205 A PL 38284205A PL 382842 A1 PL382842 A1 PL 382842A1
- Authority
- PL
- Poland
- Prior art keywords
- donepezili
- soles
- good
- pharmaceutical compositions
- compositions production
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0401850A HUP0401850A3 (en) | 2004-09-15 | 2004-09-15 | Donepezil salts for producing pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL382842A1 true PL382842A1 (pl) | 2008-01-21 |
Family
ID=89985497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL382842A PL382842A1 (pl) | 2004-09-15 | 2005-09-12 | Sole donepezilu odpowiednie do otrzymywania kompozycji farmaceutycznych |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080194628A1 (pl) |
| EP (1) | EP1817286A1 (pl) |
| CN (1) | CN101039910A (pl) |
| BG (1) | BG109855A (pl) |
| CZ (1) | CZ2007248A3 (pl) |
| EA (1) | EA200700637A1 (pl) |
| HU (1) | HUP0401850A3 (pl) |
| IL (1) | IL181827A0 (pl) |
| NO (1) | NO20071912L (pl) |
| PL (1) | PL382842A1 (pl) |
| RU (1) | RU2382032C2 (pl) |
| SK (1) | SK50342007A3 (pl) |
| UA (1) | UA88481C2 (pl) |
| WO (1) | WO2006030249A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004046497A1 (de) * | 2004-09-23 | 2006-04-06 | Helm Ag | Donepezil-Salze |
| AU2005288521A1 (en) * | 2004-09-29 | 2006-04-06 | Chemagis Ltd. | Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
| WO2007010910A1 (en) * | 2005-07-15 | 2007-01-25 | Eisai R & D Management Co., Ltd. | 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]-methyl piperidine p-toluenesulfonate or crystal thereof |
| WO2007108011A2 (en) * | 2006-03-20 | 2007-09-27 | Ind-Swift Laboratories Limited | Process for the preparation of highly pure donepezil |
| GB0609835D0 (en) * | 2006-05-18 | 2006-06-28 | Pliva Istrazivanje I Razvoj D | Impurities of a pharmaceutical product |
| EP2204364B1 (en) * | 2007-09-28 | 2013-03-20 | Tianjin Hemay Bio-Tech Co., Ltd. | Polymorphs of donepezil salts, preparation methods and uses thereof |
| WO2010033045A1 (en) * | 2008-09-16 | 2010-03-25 | Igor Anatolievich Pomytkin | Compositions and methods for prevention or treatment of beta amyloid deposition |
| US20140243278A1 (en) * | 2011-07-05 | 2014-08-28 | Sunil Sadanand Nadkarni | Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof |
| EP2586436A1 (en) | 2011-10-31 | 2013-05-01 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitor |
| WO2013078608A1 (en) | 2011-11-29 | 2013-06-06 | Ziqiang Gu | Donepezil pamoate and methods of making and using the same |
| KR101811797B1 (ko) * | 2013-04-03 | 2017-12-22 | 동국제약 주식회사 | 도네페질을 포함하는 비경구투여용 약제학적 조성물 |
| WO2018153315A1 (zh) * | 2017-02-23 | 2018-08-30 | 上海华汇拓医药科技有限公司 | 一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法 |
| EP3888636A4 (en) * | 2018-11-26 | 2022-08-17 | Ebabio Inc. | EUTECTIC MIXTURE OF DONEPEZIL AND ITS USE |
| CN120058592B (zh) * | 2023-11-28 | 2026-06-26 | 广东东阳光药业股份有限公司 | 多奈哌齐衍生物的盐及其在药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| AU731282B2 (en) * | 1996-06-07 | 2001-03-29 | Eisai Co. Ltd. | Polymorphs of donepezil hydrochloride and process for production |
| US6372760B1 (en) * | 1999-03-31 | 2002-04-16 | Eisai Co., Ltd. | Stabilized composition comprising antidementia medicament |
| ES2284519T3 (es) * | 1999-09-01 | 2007-11-16 | EISAI R&D MANAGEMENT CO., LTD. | Derivados de piperidina 4-sustituida. |
| EP1285656A4 (en) * | 2000-04-13 | 2006-07-12 | Eisai Co Ltd | ACETYLCHOLINESTERASE HEMMER CONTAINING 1-BENZYLPYRIDINIUM SALT |
| US7439365B2 (en) * | 2003-11-17 | 2008-10-21 | Usv, Ltd. | Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil) |
-
2004
- 2004-09-15 HU HU0401850A patent/HUP0401850A3/hu unknown
-
2005
- 2005-09-12 RU RU2007114082/04A patent/RU2382032C2/ru not_active IP Right Cessation
- 2005-09-12 SK SK5034-2007A patent/SK50342007A3/sk not_active Application Discontinuation
- 2005-09-12 CN CNA2005800348076A patent/CN101039910A/zh active Pending
- 2005-09-12 WO PCT/HU2005/000102 patent/WO2006030249A1/en not_active Ceased
- 2005-09-12 CZ CZ20070248A patent/CZ2007248A3/cs unknown
- 2005-09-12 EP EP05787910A patent/EP1817286A1/en not_active Withdrawn
- 2005-09-12 UA UAA200704106A patent/UA88481C2/ru unknown
- 2005-09-12 EA EA200700637A patent/EA200700637A1/ru unknown
- 2005-09-12 PL PL382842A patent/PL382842A1/pl not_active Application Discontinuation
- 2005-12-09 US US11/662,867 patent/US20080194628A1/en not_active Abandoned
-
2007
- 2007-03-08 IL IL181827A patent/IL181827A0/en unknown
- 2007-04-13 BG BG109855A patent/BG109855A/bg unknown
- 2007-04-16 NO NO20071912A patent/NO20071912L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2007248A3 (cs) | 2007-06-20 |
| HU0401850D0 (en) | 2004-11-29 |
| WO2006030249A1 (en) | 2006-03-23 |
| EP1817286A1 (en) | 2007-08-15 |
| HUP0401850A3 (en) | 2008-03-28 |
| US20080194628A1 (en) | 2008-08-14 |
| CN101039910A (zh) | 2007-09-19 |
| RU2007114082A (ru) | 2008-10-27 |
| HUP0401850A2 (en) | 2006-11-28 |
| RU2382032C2 (ru) | 2010-02-20 |
| SK50342007A3 (sk) | 2007-07-06 |
| IL181827A0 (en) | 2007-07-04 |
| UA88481C2 (ru) | 2009-10-26 |
| NO20071912L (no) | 2007-06-07 |
| BG109855A (bg) | 2008-04-30 |
| EA200700637A1 (ru) | 2007-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL223545A0 (en) | Pharmaceutical compositions | |
| ZA200700030B (en) | Pharmaceutical compositions | |
| GB0408308D0 (en) | Pharmaceutical compositions | |
| GB0513692D0 (en) | Novel pharmaceutical compositions | |
| IL189929A0 (en) | Novel dosage formulation | |
| IL188352A0 (en) | Pharmaceutical compositions | |
| GB0405033D0 (en) | Novel pharmaceutical compositions | |
| ZA200804103B (en) | Pharmaceutical compositions | |
| GB0406378D0 (en) | Novel pharmaceutical compositions | |
| PL1837019T3 (pl) | Kompozycja farmaceutyczna rozpadająca się w ustach | |
| IL192091A0 (en) | Pharmaceutical compositions | |
| GB0406380D0 (en) | Novel pharmaceutical compositions | |
| GB0404420D0 (en) | Pharmaceutical composition | |
| EP1805154A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0522045D0 (en) | Pharmaceutical compositions | |
| GB0425255D0 (en) | Pharmaceutical composition | |
| GB0407351D0 (en) | Pharmaceutical compositions | |
| GB0400971D0 (en) | Pharmaceutical compositions | |
| GB0422582D0 (en) | Pharmaceutical compositions | |
| GB0411502D0 (en) | Pharmaceutical compositions | |
| GB0514259D0 (en) | Pharmaceutical compositions | |
| ZA200803566B (en) | Pharmaceutical compositions | |
| GB0419742D0 (en) | Novel pharmaceutical compositions | |
| GB0402799D0 (en) | Pharmaceutical composition | |
| HU0400883D0 (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |